Allied Biotech

Allied Biotech EBIT Margin

The EBIT Margin (Operating Margin) of Allied Biotech (1780.TWO) as of Nov 3, 2026 is 14.17 %. In the previous year, EBIT Margin (Operating Margin) was 10.92 % — a change of 29.78% (higher).

EBIT Margin

14.17 %

YoY

29.78%

Last updated:

EBIT Margin (Operating Margin) of Allied Biotech is 2025 14.17 % . EBIT Margin (Operating Margin) of Allied Biotech was 2024 10.92 % . It decreases by 29.78% higher compared to the previous year.

Allied Biotech's operating (EBIT) margin stands at 14.2%, up from 4.3% several years earlier.

The Allied Biotech EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
19.00 TWD
Jan 1, 2019
21.35 TWD
Jan 1, 2020
16.59 TWD
Jan 1, 2021
4.26 TWD
Jan 1, 2022
27.74 TWD
Jan 1, 2023
12.31 TWD
Jan 1, 2024
10.92 TWD
Jan 1, 2025
14.17 TWD
The Allied Biotech EBIT Margin history
YEAREBIT MarginYoY
14.17 %+29.78%
10.92 %-11.32%
12.31 %-55.60%
27.74 %+551.17%
4.26 %-74.33%
16.59 %-22.27%
21.35 %+12.37%
19.00 %+44.15%
13.18 %+18.73%
11.10 %+13.33%
9.79 %+251.53%
2.79 %+76,607.12%
0.00-96.67%
0.11 %+147.98%
0.04 %-40.16%
0.07 %+9.32%
0.07 %+5.78%
0.06 %-224.91%
-0.05 %-45.05%
-0.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Allied Biotech Stock analysis

What does Allied Biotech do? Allied Biotech Corp manufactures carotenoid formulations for food, supplements, feeds, and cosmetics, with major products including beta-carotene, canthaxanthin, lycopene, lutein, coenzyme Q10, natural vitamin E, and food additives. The company sells these products to domestic markets and overseas regions such as Asia, Europe, and the Americas, targeting customers in food processing, supplement manufacturing, animal nutrition, and cosmetic industries. Its nutraceutical products serve human healthcare, animal nutraceuticals, veterinary drugs, pharmaceutical cosmetics, and biotechnology sectors. The firm's carotenoids are specifically applied in food and beverage processing, enhancing product formulations for nutritional and coloration purposes. Allied Biotech Corp's revenue streams come from the sale of these specialized formulations to manufacturers and distributors across multiple industries, including food and beverage, animal feed, and cosmetic production. The company focuses on delivering high-value biotechnology-based ingredients to global markets through its product portfolio. Allied Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Allied Biotech stock

EBIT Margin (Operating Margin) of Allied Biotech is 14.17 % in 2025.

EBIT Margin (Operating Margin) of Allied Biotech changed from 10.92 % to 14.17 %, representing a 29.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Allied Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Allied Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Allied Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Allied Biotech